
Leveraging in vitro data from novel drug candidates to prioritize antibody combinations in autoimmune disease using a QSP model of IBD
Read More

QSP model to predict clinical PK/PD of siRNA therapeutics and learnings from model development
Read More

QSP Platform for Predicting Alternate Priming Dose, Efficacy, and CRS Incidence in CD3 Bispecifics for STEAP1 Prostate Cancer
Read More

A quantitative systems pharmacology (QSP) model framework for combined clinical efficacy and hematological toxicity predictions for antibody-drug conjugates
Read More

A comprehensive multi-scale in silico approach for predicting antibody-drug conjugate clinical efficacy across oncological indications